RT @TumorBoardTues
👇🏽👇🏽👇🏽EXCELLENT #TumorBoardTuesday POINT 👇🏽👇🏽👇🏽

It’s the holiday season and many family’s are getting together. Get family history.

@MPishvaian @JohnEbbenMDPhD @jane_meisel @quirogad #OncTwitter https://twitter.com/hannahalison20/status/1605378277027332096

RT @TumorBoardTues
#SABCS22 came & went, but the exciting info for #BreastCancer is continuing to come your way via #TumorBoardTuesday!!

@jane_meisel @quirogad
📅Tues, 12/20/22 at🕗8PM ET
✅polls
⚖️in & bring citations🧾
🔁Retweet & tag 🩺colleagues
🏆Earn your🆓CME & MOC http://integrityce.com/tbt

RT @JohnEbbenMDPhD
@TumorBoardTues @shilpaonc @MPishvaian @KidneyCancer_Ca @KidneyCancer @kidneycancers @brian_rini @katy_beckermann 3/5 #TumorBoardTuesday #RenalCell
Case🎀
📷 TBT in an image

We summarized our case discussion in recurrent/stage IV #RCC

Important to consider approach to tox, especially toxicities attributable to BOTH IO & VEGFR TKI‼️

‼️Involve subspecialists EARLY when tox is noted‼️

RT @JohnEbbenMDPhD
@TumorBoardTues @shilpaonc @MPishvaian @KidneyCancer_Ca @KidneyCancer @kidneycancers @brian_rini @katy_beckermann 2/5 #TumorBoardTuesday
Case🎀
🎥 TBT in a video
Take a 👀at our quick, high-yield 🎥 summary of combo tx in #RCC.

🔹Tx needs to be personalized to the patient.
🔹Doublet IO in intermediate/poor risk disease offers better DoR, but lower ORR.

RT @JohnEbbenMDPhD
@shilpaonc @MPishvaian @TumorBoardTues @KidneyCancer_Ca @KidneyCancer @kidneycancers @brian_rini @katy_beckermann Thank you @shilpaonc for an excellent #TumorBoardTuesday and to @MPishvaian & @EmpoweringPts9 for allowing me to help build the #TBT community. Making these is fun--and a great opportunity for me to learn!

RT @TumorBoardTues
@GraceCordovano 🙏🏽Thank you for the kind words! Patient’s are integral team members toward overall treatment plan. We fully believe it’s #Teamwork that helps to empower all parties involved in caring for a patient, including THE PATIENT. Hopefully the tides continue this path. #TumorBoardTuesday

RT @GraceCordovano
Can we talk about how AMAZING #TumorBoardTuesday is for including PATIENT/PATIENT ADVOCATE as a recognized voice?!

Should be the case for regular tumor board discussions as well ✅ https://twitter.com/TumorBoardTues/status/1602689429591756801

RT @JohnEbbenMDPhD
@TumorBoardTues @KlempnerSam @MPishvaian @KoheiShitara @SteveMaronMD @SunnieSKim @LizzySmyth1 @Thalcin @ShoSatoMD1 3/5 #TumorBoardTuesday
Thurs Case🎀

📷 TBT in an image

Keep in mind
📍We always need to be mindful of AEs (mostly 🤢, vomiting, neutropenia)
📌 Fortunately, in the FAST trial, zolbetuximab + chemo with no increase in gr3 AEs vs chemo alone

RT @JohnEbbenMDPhD
@TumorBoardTues @KlempnerSam @MPishvaian @KoheiShitara @SteveMaronMD @SunnieSKim @LizzySmyth1 @Thalcin @ShoSatoMD1 2/5 #TumorBoardTuesday
Thurs Case🎀

➡️We have a new feature - 🎥 TBT in a video
Quick 📽️ take on Claudin 18.2 as a🎯in gastric/GEJ adenocarcinomas

Our recommended algorithm for now (gastric/GEJ malignancy)- check:
🔹dMMR status
🔹PD-L1 CPS
🔹HER2
🔹(Claudin18.2 coming soon?)

RT @TumorBoardTues
Set a ⏲ to join #TumorBoardTuesday on 12.06.22 at 8pm ET

📅Tues 12.06.22 at 8pm ET
👨🏻‍⚕️@KlempnerSam
📰Claudin 18.2 & new developments!!

🪵While we finalize the case, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼#OncTwitter #GastricCancer

RT @DrSGraff
I voted earlier today 🗳 🇺🇸
And now it’s time to hit the Polls again with #TumorBoardTuesday! Vote in our pre-tweet chat poll below 🗳 ⬇️ and then join us right here at 8 PM ET to 🗣talk breast cancer! #bcsm https://twitter.com/tumorboardtues/status/1590019896251146241